Therapeutic approaches to acute pulmonary embolism;Therapeutisches vorgehen bei akuter lungenembolie

Internist

Volumn 45, Issue 5, 2004, Pages 540-548

  Reissig A ^a   Kroegel, C ^a  

^a FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

Author keywords

Anticoagulant therapy; Low molecular weight heparins; Pulmonary embolism; Thrombolytic treatment; Vitamin K antagonists

Indexed keywords

ALTEPLASE; ANTICOAGULANT AGENT; ANTIVITAMIN K; D DIMER; HEPARIN; IDRAPARINUX; LOW MOLECULAR WEIGHT HEPARIN; PROTAMINE; STREPTOKINASE; TINZAPARIN; TROPONIN; UROKINASE;

ALGORITHM; ANTICOAGULANT THERAPY; CHEMOPROPHYLAXIS; CLINICAL EXAMINATION; COMPUTER ASSISTED TOMOGRAPHY; DISEASE CLASSIFICATION; ECHOCARDIOGRAPHY; FIBRINOLYTIC THERAPY; HEPARINIZATION; HUMAN; LUNG EMBOLISM; LUNG SCINTISCANNING; REVIEW; SECONDARY PREVENTION; TREATMENT PLANNING;

ACUTE DISEASE; ANTICOAGULANTS; CRITICAL CARE; FIBRINOLYTIC AGENTS; HEPARIN, LOW-MOLECULAR-WEIGHT; HUMANS; PATIENT CARE MANAGEMENT; PULMONARY EMBOLISM; TRIAGE; VITAMIN K;

EID: 2942560712     PISSN: 00209554     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00108-004-1168-9     Document Type: Review

References (33)

1. Ashton RW, Daniels CE, Ryu JH et al. (2003) Correspondence. Thrombolytic therapy in patients with submassive pulmonary embolism. N Engl J Med 348: 357-359
2. Beckman JA, Dunn K, Sasahara AA, Goldhaber SZ (2003) Enoxoparin monotherapy without oral anticoagulation to treat acute symptomatic pulmonary embolism. Thromb Haemost 89: 953-958
3. Böttiger BW, Bach A, Böhrer H, Martin E (1993) Die akute Thromboembolie der Lunge. Klinik - Pathophysiologie-Diagnostik-Therapie. Anaesthesist 42: 55-73
4. de Monye W, Sanson BJ, Mac Gillavry MR, Pattynama PMT, Büller HR, van den Berg-Huysmans AA, Huisman MV (2002) Embolus location affects the sensitivity of a rapid quantitative D-dimer assay in the diagnosis of pulmonary embolism. Am J Respir Crit Care Med 165: 345-348
5. Eriksson H, Wahlander K, Lundström T, Billing-Clason S, Schulman S (2003) Extended secondary prevention with oral direct thrombin inhibitor ximelagatran for 18 months after 6 months of anticoagulation in patients with venous thromboembilism: a randomized, placebo-controlled trial. J Thromb Haemostasis 1 (Suppl): OC005
6. Giannitsis E, Müller-Bardorff M, Kurowski V, Weidtmann B, Wiegand U, Kampmann M, Katus HA (2000) Independent prognostic value of cardiac troponin T in patients with confirmed pulmonary embolism. Circulation 102: 211-217
7. Goldhaber SZ (1998) Pulmonary embolism. N Engl J Med 339: 93-104
8. Goldhaber ST, Visani L, de Rosa M (1999) Acute pulmonary embolism: clinical outcomes in the International Cooperative Pulmonary Embolism Registry (ICOPER). Lancet 353: 1386-1389
9. Goldhaber SZ (2001) Thrombolysis in pulmonary embolism. A large-scale clinical trial is overdue. Circulation 104: 2876-2878
10. Grosser KD (1988) Akute Lungenbembolie. Behandlung nach Schweregraden. Dtsch Ärztebl 85: B587-B594
11. Gulba DC, Schmid C, Borst HG, Lichtlen P, Dietz R, Luft FC (1994) Medical compared with surgical treatment for massive pulmonary embolism. Lancet 343: 576-577
12. Hejna M, Radere M, Zielinski C (1999) Inhibition of metastases by anticoagulants. J Natl Cancer Inst 91: 22-36
13. Jacob H, Vahl C, Lange R, Micek M, Tanzeem A, Hagl S (1995) Modified surgical concept for fulminant pulmonary embolism. Eur J Cardiothorac Surg 9: 557-560
14. Kearon C, Ginsberg JS, Kovacs MJ et al. (2003) Comparison of low-intensity warfarin therapy with conventional-intensity warfarin therapy for long-term prevention of recurrent venous thromboembolism. N Engl J Med 349: 631-639
15. Konstantinides S, Geibel A, Olschewski M, Kaspar W, Hruska N, Jäckle S, Binder L (2002) Importance of cardiac troponins I and T in risk stratification of patients with acute pulmonary embolism. Circulation 106: 1263-1268
16. Koopmann MM, Buller HR (2003) Short- and long-acting synthetic pentasaccharides. J Intern Med 254: 335-342
17. Kovacs MJ, Anderson D, Morrow B, Gray L, Touchie D, Wells PS (2000) Outpatient treatment of pulmonary embolism with Dalteparin. Thromb Haemost 83: 209-211
18. Kroegel C, Reißig A (2003) Principle mechanisms underlying venous thromboembolism: epidemiology, risk factors, pathophysiology and pathogenesis. Respiration 70: 7-30
19. Kroegel C, Reißig A, Bonnet R et al. (2003) Aktuelle Entwicklungen in der Pneumologie 2002 - Teil 1. Update. Med Klin 98: 30-56
20. Lee AYY, Levine MN, Baker RI et al. for the randomized comparison of Low-Molecular-Weight Heparin versus oral anticoagulant therapy for the prevention of recurrent venous thromboembolism in patients with cancer (CLOT) Investigators (2003) Low-molecular-weight heparin versus a coumarin for the prevention of recurrent venous thromboembolism in patients with cancer. N Engl J Med 349: 146-153
21. Levine MN, Lee AYY (1999) Treatment of venous thromboembolism in cancer patients. Semin Thromb Hemost 25: 245-249
22. Meissner E, Fabel H (1990) Akute Lungenembolie. Klinik, Diagnostik und Therapie. Arzeneimitteltherapie 8: 177-192
23. Morpurgo M, Schmid C (1995) The spectrum of pulmonary embolism. Clinicopathologic correlations. Chest 107: 18-20
24. Padosch SA, Motsch J, Böttiger BW (2002) Thrombolyse während der kardiopulmonalen Reanimation. Anaesthesist 51: 516-532
25. Perrier A, Bounameaux H (2001) Cost-effective diagnosis of deep vein thrombosis and pulmonary embolism. Thromb Haemost 86: 475-487
26. Reißig A, Heyne J-P, Kroegel C (2001) Sonography of lung and pleura in pulmonary embolism: sonomorphologic characterization and comparison with spiral CT scanning. Chest 20: 1977-1983
27. Reißig A, Richartz B, Kroegel C (2001) Diagnostik der Lungenarterienembolie. Dtsch Med Wochenschr 126: 857-863
28. Stein PD, Henry JW (1995) Prevalence of acute pulmonary embolism among patients in a general hospital and at autopsy. Chest 108: 978-981
29. Stein PD, Henry JW (1997) Clinical characteristics of patients with acute pulmonary embolism stratified according to their presenting syndromes. Chest 112: 974-979
30. Tapson VF, Witty LA (1995) Massive pulmonary embolism. Diagnostic and therapeutic strategies. Clin Chest Med 16: 329-340
31. The Columbus Investigators (1997) Low-molecular-weight heparin in the treatment of patients with venous thromboembolism. N Engl J Med 337: 657-662
32. Torbicki A, van Beek EJR, Charbonnier B, Meyer G, Morpugo M, Palla A, Perrier A (2000) Task Force Report. Guidelines on diagnosis and management of acute pulmonary embolism. Eur Heart J 21: 1301-1336
33. Walther A, Böttiger BW (2002) Die akute Lungenarterienembolie. Anaesthesist 51: 427-445